Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quality Horizons Pharmtech (QHP) is a specialized Contract Development and Manufacturing Organization (CDMO) based in Suzhou, China, focusing on small molecule drug development. The company provides a comprehensive suite of services including process chemistry research, analytical development, and GMP-compliant manufacturing of advanced intermediates and Active Pharmaceutical Ingredients (APIs). QHP supports global pharmaceutical and biotech clients from early-stage lead optimization through to commercial-scale production. Their technical expertise encompasses complex chemical transformations, flow chemistry, and high-pressure reactions. By leveraging its state-of-the-art R&D center and manufacturing facilities, the company aims to accelerate the drug development timeline for its partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Quality Horizons Pharmtech.